Treatment of primary melanoma of the lung monitored by 5-S-cysteinyldopa levels.

Abstract

Malignant melanoma originating outside the skin is very rare, whereas primary malignant melanoma of the lung is extremely rare. 5-S-Cysteinyldopa (5-S-CD), a melanin metabolite, has been reported to be a prognostic marker for cutaneous malignant melanoma. This is the first report in the English language literature dealing with primary malignant melanoma of the lung using serum 5-S-Cysteinyldopa levels to monitor the effects of surgery and chemotherapy.

• Authors: Kei Shikuma, Mitsugu Omasa, Yojiro Yutaka, Masato Okuda, Toshihiko Taki
• Journal: The Annals of thoracic surgery (Ann Thorac Surg) Vol. 87 Issue 4 Pg. 1264-6 (Apr 2009) ISSN: 1552-6259 [Electronic] Netherlands
• PMID: 19324166 (Publication Type: Case Reports, Journal Article)

Chemical References

• Biomarkers
• Cysteinyldopa

Topics

• Aged
• Biomarkers (blood)
• Cysteinyldopa (blood)
• Humans
• Lung Neoplasms (blood, surgery)
• Male
• Melanoma (blood, surgery)
• Pneumonectomy